KRISTEN DIAMOND: Open Payments
NPI 1851849574 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$513 in 27 payments from 7 companies in 2025. Trend: 2023 $326 · 2024 $595 · 2025 $513
Food & beverage: $513
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $194 |
| Novartis Pharmaceuticals Corporation | 5 | $139 |
| Novo Nordisk Inc | 3 | $55 |
| PFIZER INC. | 2 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| Chiesi USA, Inc. | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: LEQVIO, CAMZYOS, ELIQUIS, VYNDAQEL, Wegovy, JARDIANCE, JUXTAPID, WAINUA.
Industry payments across CT — which companies pay providers there.
